Drug intelligence / Profile preview

Wu-Zhi-Fang-Guan-Fang decoction

Development stage: Unknown
Lead developer: The First Affiliated Hospital of Guangzhou Medical University
Administration: Oral

Overview

Wu-Zhi-Fang-Guan-Fang decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by the First Affiliated Hospital of Guangzhou Medical University for the prevention of COVID-19. It was evaluated in a prospective clinical study in China as a prophylactic intervention for individuals who had close contact with confirmed COVID-19 cases. The decoction is designed to enhance the body's immune response and provide antiviral protection according to TCM principles, though its specific molecular targets are not fully characterized in conventional pharmacological terms. It is typically administered as an oral solution prepared from a mixture of botanical extracts.

Other names: Wu-Zhi-Fang-Guan-FangWuzhifangguanfang

Beyond the preview

Go deeper on Wu-Zhi-Fang-Guan-Fang decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wu-Zhi-Fang-Guan-Fang decoction.

Explore the full profile